Thursday, September 21, 2017 2:53:09 PM
West Coast President and Co-head of Capital Markets
Mr. Walters joined RHK Capital in June 2017. Mr. Walters had previously worked at Detwiler Fenton & Co and prior to that, he co-founded Monarch Bay Securities, LLC, a FINRA member broker dealer, in 2006. From 2002-present Mr. Walters is a principal with Laguna Advisory Partners, LLC, a firm that provides growth capital and advisory services to market leading growth businesses. Mr. Walters is actively involved with alternative energy and GRID edge solution providers. These alternative energy businesses include providers of Natural Gas and Propane fuel systems and engines for both transportation and stationary power applications as well as software developers that create operating systems for management of industrial and commercial users of distributed power. From 1992 through 2000 he was Executive Vice President of Managing Director in charge of Capital Markets for Roth Capital (formerly Cruttenden Roth) where he was instrumental in building the company’s revenues from $7 million to $65 million. As an equity partner, he managed the capital markets group and was lead manager on over 100 public offerings, and was responsible for the syndication, distribution and after-market trading of the public offerings. He managed the public offerings for Cruttenden Roth, which was the most prolific public underwriter in the U.S. for deals whose post-offering market cap was less than $100 million. Mr. Walters sat on the Roth’s Board of Directors from 1994 through 2000. Prior to Cruttenden Roth, he was Vice President for both Drexel Burnham Lambert and Donaldson Lufkin and Jenrette in Los Angeles, and he ran a private equity investment fund. Mr. Walters’ wife Mimi represents CA-45 in the United States House of Representatives. They have four children and live in Orange County, California. Mr. Walters earned a B.S. in Bioengineering from the University of California, San Diego.
Contact David Walters:
Phone: (949) 300-3020
Email: dwalters@rhk.capital
http://rhkcapital.com/portfolio_page/david-walters/
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM